
Speaker

John-Clark Levin
What if the next leap in human healthspan is not driven by biology alone, but by the intelligence we build to accelerate it?
Join us on August 25th from 5:30 to 7:30 PM for an exclusive evening presented by Beusail Longevity at Patriot Bank in Beverly Hills.
This intimate gathering will bring together a curated community for an engaging conversation on artificial general intelligence, superintelligence, and the emerging shift these technologies are creating across medicine and the life sciences.
The evening will begin with a private networking reception designed to foster meaningful connection among individuals passionate about health innovation, longevity science, human performance, and the future of medicine.
The featured presentation and interactive Q and A will be led by John Clark Levin, head of research at Kurzweil Technologies, the lab of Ray Kurzweil, Google's chief futurist from 2012 to 2025 and the world's foremost authority on the future of artificial intelligence.
During the conversation, John Clark will explore the roadmap to artificial superintelligence, the emerging capabilities of AI, and what these advances could mean for the future of human health. Drawing from sixteen years of research at Claremont, Harvard, and Cambridge, he will examine how AI alignment and safety intersect with applications poised to transform medicine and the life sciences.
The discussion will examine how superintelligent systems may reshape drug discovery, diagnostics, and personalized care, and why keeping these systems aligned with human flourishing may be one of the most consequential challenges of our time.
Attendees will gain insight into the emerging science of AI driven medicine, the roadmap toward artificial general intelligence, and why the future of healthcare may increasingly depend on the trajectory of the technology built to serve it.
Whether your interest lies in longevity, artificial intelligence, biotechnology, or health innovation, this evening will offer a thought provoking perspective on the future of human health in an age of superintelligence.
Date: August 25th
Time: 5:30 to 7:30 PM
Location: Patriot Bank, 9629 Brighton Way, Beverly Hills, CA 90210
Parking**: A pay to park lot is available at 461 N Bedford Drive, or nearby street parking.
What You Will Learn
✓ A thought provoking conversation on AGI, superintelligence, and the future of medicine
✓ Insight into the roadmap toward artificial superintelligence and its emerging capabilities
✓ Perspectives on how AI alignment and safety intersect with human flourishing
✓ A deeper understanding of how AI is poised to transform drug discovery, diagnostics, and personalized care
✓ Exploration of how these technologies could reshape healthspan, longevity, and long term wellbeing
✓ Live Q and A with John Clark Levin on AGI, superintelligence, and the future of medicine
✓ Meaningful networking with a high caliber community interested in health innovation and longevity
About Our Speaker
John-Clark Levin is the head of research at Kurzweil Technologies, the lab of Ray Kurzweil—Google’s chief futurist from 2012-2025 and the world’s foremost authority on the future of artificial intelligence. There, John-Clark conducts foresight about the emerging capabilities of AI, and especially the roadmap to artificial superintelligence. This work was featured in Kurzweil’s The Singularity Is Nearer, which became an instant New York Times bestseller. For the past 16 years, John-Clark has studied AI and its impacts at Claremont, Harvard, and Cambridge, where his research focuses on methods of keeping AI safe and aligned with human flourishing, and on applications of AI to transform medicine and the life sciences. He is also an advisor to the brain-computer interface company Subsense BCI and a senior fellow at the Yorktown Institute. John-Clark has lectured at dozens of institutions including Georgetown University, RAND, and the Centre for the Study of Existential Risk—and his commentary has appeared in numerous publications such as the Wall Street Journal, TIME Magazine, and MIT Technology Review.
